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The recently analyzed sequences of the nonpathogenic prototype strain Hill and the mouse-virulent strain Barty of the
human echovirus 9 differ particularly in an insertion coding for an RGD motif at the C-terminus of the capsid protein VP1
in the genome of strain Barty. To investigate molecular determinants of virulence, we generated a panel of recombinant
viruses derived from cDNA clones of strains Hill and Barty. In this communication, we show that the mouse-pathogenic
character of strain Barty correlates with a 310-aa segment including the RGD motif. By mutating the RGD to an RGE tripetide,
the infectivity of the resulting echovirus 9 clones for GMK cells is lost. Furthermore, we could show that synthetic peptides
containing the RGD sequence influence binding of mouse-virulent echovirus 9 strains to GMK cells, whereas binding of
apathogenic strains is not affected. These results suggest that the RGD motif is a significant factor affecting pathogenicity
of echovirus 9 strains. q 1997 Academic Press
INTRODUCTION virus B4 are located in the capsid proteins VP1 or VP4
(Caggana et al., 1993; Ramsingh and Collins, 1995). To
Picornaviruses are small icosahedral particles with a gain further information, we constructed recombinant
coat made up of 60 copies of each of four capsid proteins full-length clones composed of sequences of the aviru-
(VP1 to VP4) enclosing a single-stranded, positive-sense lent E9/Hill and of the virulent E9/Barty and mapped a
RNA genome of approximately 7500 nucleotides. The fragment affecting echovirus 9 virulence.
RNA is translated into a single polyprotein cleaved by In previous studies we have shown that an insertion
virus-encoded proteases into mature viral proteins (for including an arginine-glycine-aspartic acid (RGD) motif
review see Rueckert (1996)). Within the picornavirus fam- is the most striking difference between E9/Hill and E9/
ily, echoviruses belong to the genus enterovirus, which Barty (Zimmermann et al., 1995, 1996). RGD motifs may
also includes polioviruses and coxsackieviruses. The function as cell recognition sites of adhesive proteins
prototype strain Hill of echovirus 9 (E9/Hill) was isolated responsible for a number of cell–cell interactions, e.g.,
in 1953 from the rectal swab of a healthy child and shown anchorage, traction for migration, or differentiation of
to be nonpathogenic for newborn mice (Ramos-Alvarez cells (Hynes, 1992; Ruoslahti and Pierschbacher, 1987).
and Sabin, 1954). In contrast, other echovirus 9 strains, Certain picornaviruses apparently use this sequence as
e.g., strain Barty (E9/Barty) isolated from the cerebrospi- a receptor binding site by interacting with cellular inte-
nal fluid of a child suffering from aseptic meningitis, are grines (Berinstein et al., 1995; Fox et al., 1989; Roivainen
highly virulent in newborn mice (Eggers and Sabin, 1959). et al., 1991, 1994; Stanway et al., 1994).
Notwithstanding the fact that human echoviruses may In this communication it is suggested that the RGD
be pathogenic entailing diseases ranging from slight ill- motif is an important determinant for pathogenicity of
ness to severe infections like aseptic meningitis or en- echovirus 9, since virulence in newborn mice correlates
cephalitis (Melnick, 1996; Morens et al., 1991), the patho- with the presence of this motif.
genicity of echoviruses is not sufficiently understood. For
certain picornaviruses, such as poliovirus (Evans et al., MATERIALS AND METHODS
1985; Ren et al., 1991; Westrop et al., 1989), coxsackie-
Viruses and cellsvirus B3 (Tu et al., 1995), and Theiler’s murine encephalo-
myelitisvirus (Fu et al., 1990), major determinants of viru- The origin of echovirus 9 strains Hill and Barty has
lence are mapped to the 5*-nontranslated region. On the been described elsewhere (Zimmermann et al., 1995,
other hand, sites which influence virulence of coxsackie- 1996). Cell culture experiments using GMK cells and the
preparation of virus stocks were performed as previously
published (Rosenwirth and Eggers, 1978). All cell culture1 To whom correspondence and reprint requests should be ad-
media were purchased from Life Technologies, Inc. (Eg-dressed. Fax: (/49) 221-407490. E-mail: Birgit.Nelsen-Salz@medizin.
uni-koeln.de. genstein, Germany).
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Site-directed mutagenesis of the RGD motif
The RGD motif was mutated to an RGE tripeptide by
PCR utilizing primers that contained one mismatch. For
that purpose, two PCRs were performed using the primer
pairs E9B-C7-1 (nt 3313–3335)/E9B-43 (nt 3887–3868)
and E9B-C7-2 (nt 3335–3313)/E9B-47 (nt 3006–3022), re-
spectively. Clones pE9B-180 and pE9B-159, respectively,
served as templates. Thirty-five cycles were accom-
plished as follows: 947 for 60 sec, 427 for 60 sec, and
727 for 60 sec. The resulting DNA fragments of 574 and
329 bp, respectively, were purified and used for a second
‘‘recombinant’’ PCR using primers E9B-43 and E9B-47,
each located at the end of one of the fragments. The
resulting 881-bp DNA molecule was digested with MluI
(nt 3264) and XbaI (nt 3911) and cloned into correspond-
ing sites of the plasmids pE9-C1 and pE9-C2, respec-
tively (Fig. 1). Since the sequences of the primers E9B-
C7-1 and E9B-C7-2 reveal the mutation T3326G—or A3326C
on the corresponding strand—the RGD motif is changed
to an RGE tripeptide.
In vitro transcription
FIG. 1. Maps of chimeric full-length echovirus 9 cDNAs used to
generate recombinant viruses. The viral RNA as well as the genome The plasmids containing full-length genomes were lin-
organization (thin line, untranslated regions; thick line, open reading earized with NotI cleaving four nucleotides (GGGC) be-
frame) and the restriction sites used for the construction of the chimeric
yond the 3*-end of the poly(A) tail. The reaction mixturegenomes (shown below) are depicted on top. The designation of each
was subsequently extracted with phenol, the DNA yieldplasmid is shown at the right. Open bar, Hill sequences; filled bar,
Barty sequences. The asterisk indicates the full-length genome of the was estimated on an agarose gel, and 1 mg DNA was
apathogenic E9/Hill (Zimmermann et al., 1995). used for in vitro transcription performed with T7 RNA
polymerase. RNA size and yields were checked by gel
electrophoresis under denaturing conditions.
Synthetic peptides
Transfection and generation of recombinant virusThe oligopeptide RGD (Production No. H-1830) was
stocksbought from Bachem (Switzerland). Random oligopep-
tides (GRGDS)4 , LTFPRGDNVATA, and LTFPRGENVATA If not stated otherwise, GMK cell monolayers were
were kindly provided by Jochen Ku¨hn (Institut fu¨r Virolo- transfected in the presence of DEAE dextran (Kriegler,
gie der Universita¨t zu Ko¨ln). 1990) with slight modifications to the published protocol,
i.e., chloroquine was omitted, and instead of 6-well
Construction of chimeric echovirus 9 genomes dishes, 24-well cluster dishes were used. Therefore, the
volume of the buffers added was appropriately reduced.
The plasmid pE9H-475ic of E9/Hill (Zimmermann et al.,
Transfection experiments with lipofectin (Life Technolo-
1995) carrying a T7 RNA polymerase promoter just in
gies, Inc.) were carried out according to the manufactur-
front of the full-length viral genome and the clone pE9B
er’s recommendations. Twenty-four to 48 hr after trans-
containing the full-length cDNA of E9/Barty were used
fection, cell monolayers which had developed a charac-
for cloning procedures. pE9B was constructed by ligation
teristic cythopathic effect (CPE) were harvested and used
of overlapping fragments of the Barty genome described
to infect fresh cells. Viral stocks were prepared after an
elsewhere (Zimmermann et al., 1996). Recombinants
additional passage in GMK cells, and virus titers were
were created by replacing specific fragments of pE9H-
determined by plaque assay.
475ic by homologous sequences derived from pE9B (Fig.
1). The restriction endonuclease sites used for construc- Determination of virulence and viral replication in
tion were AspI (nt 1880 Hill genome/nt 1881 Barty ge- newborn mice
nome), AvrII (nt 2981/2982), and XbaI (nt 3880/3911). The
constructs were checked by restriction endonuclease di- NMRI mice less than 24 hr old were inoculated subcu-
taneously with 20 ml PBS containing virus of specifiedgestions and sequencing of the cloning sites. Plasmids
are designated ‘‘p’’ (e.g., pE9-C1) and the resulting recom- concentrations. For determination of virulence, the ani-
mals were observed over a period of 14 days at leastbinant viruses ‘‘r’’ (e.g., rE9-C1).
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once a day, and clinical symptoms (paresis) as well as
death were recorded. To measure viral replication in
muscle tissue, on Day 3 and 5 p.i. in each case two mice
were sacrificed and frozen at 0207. Mouse carcasses
were individually ground in a mortar to a 20% suspension
in MEM medium. The suspensions were centrifuged at
5000 rpm for 5 min and the supernatants stored at 0207
until subsequent determination of virus infectivity by
plaque assay. All animal experiments were performed in
accordance with institutional and national guidelines.
Competition-binding assay FIG. 2. Estimate of the amount of in vitro transcribed RNA under
denaturing conditions. After in vitro transcription, 1/10 of the reaction
GMK cells were grown to confluence in six-well plates. mixture was loaded on an agarose gel, and the remaining 1/9 was
Fifty microliters of 7.5 mM peptides in PBS were added used for transfection experiments. (1) RNA ladder, (2) pE9H-475ic, (3)
pE9-C1, (4) pE9-C2, (5) pE9-C4, (6) pE9-C8, (7) pE9-C9, (8) pE9-C10, (9)to cell monolayers which had previously been washed
pE9-C11, (10) RNA ladder.with PBS. Following a 45-min incubation at room temper-
ature (RT) 100 PFU of virus in PBS were added. After an
additional incubation for 15 min at RT, the unadsorbed and the C-terminal part of strain Barty (Fig. 1). In addition,
inoculum was thoroughly removed and 5 ml of 0.75% a recombined 2B protein composed of the N-terminus of
agarose in DMEM was added. The amount of adsorbed E9/Barty and the C-terminus of E9/Hill is created.
infectious virus was scored by counting plaques after Finally, clones pE9-C9, -C10, and -C11 were obtained
incubation at 377 for 2 to 3 days. by site-directed mutagenesis using modified PCR prim-
ers as described under Materials and Methods. They
Virus labeling and viral adsorption assay differ from the corresponding clones pE9-C8, -C2, and
-C1, respectively, in the replacement of the RGD tripep-In order to label viral proteins radioactively, confluent
tide by an RGE at the C-terminus of VP1.cells were infected with the appropriate virus stock in
methionine-free medium. Three hours after infection, 20
Infectivity of the in vitro transcribed RNAs in cellmCi [35S]methionine per tissue culture flask (175 cm2)
culturewas added. Labeled virus was harvested as soon as
complete cytopathic effects had developed. GMK cell RNA of the recombinant clones was transcribed in
monolayers grown in six-well dishes were incubated in vitro and yield was estimated on an agarose gel under
the presence of RGD peptides for 30 min at room temper- denaturing conditions (Fig. 2). Transfection experiments
ature prior to the addition of labeled virus. Binding assays using equal amounts of RNA of the clones pE9B, pE9-
were performed by incubation at 47. After 60 min, cell C1, -C2, and -C4, respectively, led to productive infection
monolayers were washed with PBS and the remaining accompanied by a typical CPE.
cell-associated counts determined in a scintillation When the recombinants were compared in single-cy-
counter. cle growth studies, all strains showed eclipse times of
2 hr and reached similar maximum virus yields at 6 to 8
RESULTS hr (Fig. 3). Accordingly, the indicated recombinants reveal
unimpaired and comparable capacity of reproduction inConstruction of recombinant virus genomes
cell culture.
Neither construct pE9-C10 nor pE9-C11 give rise toIn order to map the sequence responsible for mouse
virulence of E9/Barty, recombinant clones containing dif- measurable amounts of recombinant viruses in trans-
fection experiments. This indicates that substitution offerent amounts of E9/Hill and E9/Barty sequences were
created (Fig. 1). Clones pE9-C2, pE9-C1, and pE9-C4 con- the RGD motif by an RGE tripeptide apparently abol-
ishes the infectivity of the recombinant clones. Further-sist of 1880, 2981, and 3880 nucleotides, respectively, of
E9/Hill in front of the remaining 3* part of E9/Barty. The more, no recombinant viruses could be harvested from
transfection experiments using RNA of the clones pE9-breakpoints are located in VP2, VP1, and 2B, respectively,
leading to the appropriate fusion proteins composed of C8 nor pE9-C9. Due to the RGD r RGE replacement,
it seemed unlikely that clone pE9-C9 would be infec-the N-terminus of E9/Hill and the C-terminus of E9/Barty.
Clone pE9-C8 carries an internal 930-nt fragment ex- tious. However, clone pE9-C8 was expected to code
for an infectious RNA.tending from position 2982 (VP1) to 3911 (2B) of E9/Barty
in the genetic background of E9/Hill. In this construct, In the case of the noninfectious constructs pE9-C8,
-C9, -C10, and -C11, additional transfection experimentsthe same chimeric VP1 protein as in clone pE9-C1 is
generated; i.e., the N-terminal part consists of strain Hill were carried out using lipofectin instead of DEAE dextran
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of E9/Hill need not essentially affect virulence of E9/
Barty.
Viral replication in newborn mice
To examine viral capacity to replicate in mouse tissue,
newborn NMRI mice were infected with undiluted recom-
binant virus. On Days 3 and 5 p.i., respectively, two mice
in each case were sacrificed, and the virus content was
determined by plaque assay. It can readily be seen that
virus strains containing the 3* part of strain E9/Barty at
least from position 2982 on (rE9-C1 and -C2) replicate to
high titers in muscle tissue (Fig. 5). Replacing a further
310 aa (nt 2982–3911) comprising the C-terminal part of
VP1 including the RGD motif, protease 2A, and the N-
terminal part of 2B (Fig. 6) of E9/Barty by E9/Hill se-
FIG. 3. Single-cycle growth kinetics for the indicated cDNA-derived quences (rE9-C4) led to a virus incapable of replicating
viruses. GMK cells were inoculated (multiplicity of infection of 10 to
in muscle tissue of newborn mice (Fig. 5), thus compara-50) and incubated for 30 min at room temperature. Subsequently, the
ble to E9/Hill and rE9 H-475ic (Zimmermann et al., 1995).cultures were washed and transferred to 377. At the indicated times,
cells were lysed to obtain free and cell-bound virus, and titers of total It should be noted that rE9-C4 replicates readily in cell
virus produced were determined by plaque assay. rE9H, rE9H-475ic. culture (Fig. 3).
Effect of RGD peptides on infectivity and attachment
in order to possibly increase transfection efficiencies, of different echovirus 9 strains
but these experiments, too, failed to yield measurable
Three oligopeptides composed of the RGD motif withamounts of infectious viruses. To make sure that the
different flanking sequences were tested for efficacy tocorrect sequence was conserved during the different
inhibit virus infectivity in cell culture (Table 2). The oligo-cloning steps, construction of the recombinant cDNA was
peptide with the sequence (GRGDS)4 —comprising fourrepeated three times using independent insert fragments
RGD sites—was most competent and inhibited echovi-which in other constructs gave rise to infectious virus.
rus 9 strains containing an RGD motif as effective (aboutFurthermore, the breakpoints were sequenced. Five to
70% inhibition) as coxsackievirus A9, which is known to10 independent clones per experiment were tested. How-
adsorb via a functional RGD motif to the vitronectin re-ever, no culture developed a cytopathic effect after trans-
ceptor (Roivainen et al., 1994). Furthermore, two addi-fection nor could infectious virus be isolated after transfer
tional RGD-containing peptides (RGD and LTFPRGDNV-of the supernatants to fresh cells.
ATA) were also capable of inhibiting infection, although
Pathogenicity of chimeric viruses in newborn mice to a slightly lesser extent. The control peptide LTFPRG-
ENVATA—differing from the oligopeptide LTFPRGDNV-After inoculation of newborn mice with E9/Hill, rE9H-
ATA only by replacement of the aspartic acid by glutamic475ic, or rE9-C4, respectively, no pareses were detected.
acid—showed no inhibitory effect. On the other hand,In contrast, E9/Barty and rE9B, rE9-C1 or rE9-C2 cause
neither peptide had an effect on the infectivity of virusesparalysis pathognomonic for coxsackie A viruses in all
lacking the RGD sequence (E9/Hill and rE9-C4), indicat-mice infected. In general, pareses were first observed
ing that the RGD interaction is specific.on Day 4 p.i., and from Day 6 p.i. on mice died. The
In order to further characterize the inhibitory effect oflethality of the mouse-virulent strains ranged from 60 to
the RGD-containing peptides, a series of experiments100%, whereby a higher lethality was correlated with a
using radioactively labeled viruses was carried out (Fig.lower weight of the individual mouse, e.g., as seen in
7). By comparing the ratio of bound and free virus in thelarge litters (Fig. 4). In large litters the individual mouse
absence or in the presence of the peptides, respectively,and accordingly its muscle mass are smaller, which
it could be demonstrated unequivocally that the virus/leads more readily to destruction of at least 50% of the
receptor attachment is being affected. Hence, RGD-con-skeletal muscle tissue, a prerequisite for manifest pare-
taining peptides inhibit adsorption of mouse virulentsis (Bu¨ltmann et al., 1983).
echovirus 9 strains, and, consequently, production ofIn the case of E9/Barty and rE9-C1 the dose of virus
plaques (Table 2).paralyzing 50% of the infected animals (PD50 , expressed
in PFU per mouse) was determined and turned out to be
DISCUSSION
nearly identical (Table 1). This result is compatible with
the view that the nontranslated 5* end, the capsid pro- Although antigenically related, echovirus 9 strains E9/
Hill and E9/Barty differ clearly in regard to their mouseteins VP4, VP2, and VP3, and the N-terminal part of VP1
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FIG. 4. Progress of clinical symptoms after inoculation of newborn NMRI mice depending on litter size. Litters with less (A) or more (B) mice
were used for infection experiments with rE9-C1 and rE9-C2, respectively, and the inoculated animals were observed over a period of 14 days.
Gray boxes indicate healthy animals, dark-gray boxes indicate paralytic animals, and black boxes denote dead mice.
virulence. Infection of newborn mice with E9/Barty results A panel of recombinant viruses constructed from the
virulent and nonpathogenic variant were used to definein virus replication in the muscle tissue with concomitant
destruction of skeletal muscle and paralysis, whereas more closely the molecular basis of virulence. It was
shown that the two chimeric echovirus 9 strains con-after inoculation with E9/Hill no virus replication is de-
tectable (Eggers and Sabin, 1959). Sequence compari- taining — in addition to other sequences — the 310-aa
fragment with the RGD motif (rE9-C2, rE9-C1) inducesons revealed an insertion including an RGD motif at the
C-terminus of VP1 of E9/Barty (Zimmermann et al., 1996). paresis and paralysis in newborn mice comparable to
the parental strain E9/Barty (Table 1). The 5* part ofSince the tripeptide RGD is shown to mediate cell surface
receptor recognition during attachment of echovirus 22 E9/Hill up to position 2981 does not appear to affect
virulence (rE9-C1) nor is the 3* half of E9/Barty startingas well as coxsackievirus A9 and foot-and-mouth dis-
ease virus (Berinstein et al., 1995; Fox et al., 1989; Roi- from position 3911 sufficient to induce in a nonpatho-
genic E9/Hill background a virulent phenotype (rE9-vainen et al., 1991, 1994; Stanway et al., 1994), we ana-
lyzed the possible significance of this motif for mouse C4) — notwithstanding the fact that both constructs
replicate efficiently in cell culture. These data pointvirulence of echovirus 9.
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TABLE 1
Virulence of Different Echovirus 9 Strains after Subcutaneous Inoculation of Newborn Mice
Inoculum (PFU/20 ml)
Virus 106 104 102 101 100 PD50 (PFU)a
Barty b 14/14c 12/12 12/13 7/15 0/13 1.5 1 102
Hillb 0/14 — d — — — —
rE9-C1e 10/10 12/13 10/13 5/16 0/14 1.7 1 102
rE9-C2e 14/14 12/12 — — — —
rE9-C4e 0/13 — — — — —
rE9H-475ice 0/14 — — — — —
a PD50 is the virus dose paralyzing 50% of infected animals.
b Original virus isolates.
c Number of animals exhibiting paresis/number of animals inoculated.
d Not tested.
e Recombinant virus strains.
to the importance of the RGD-containing fragment for RNA. The replacement of aspartic acid (D) by the chemi-
cally related glutamic acid (E) is not expected to inducevirulence of echovirus 9.
Furthermore, competition experiments using RGD pep- extensive rearrangements in VP1. Hence, the function of
VP1—except that of the RGD motif itself—should betides reveal that the RGD motif of E9/Barty is functionally
relevant. Attachment of all RGD-comprising viruses is maintained, and, therefore, the loss of infectivity is pre-
sumably the consequence of the altered RGD. Since,inhibited by these peptides (Table 2, Fig. 7) to the same
extent as coxsackievirus A9, which has already been even after repeated attempts to transfect GMK cells with
in vitro-derived RNA from pE9-C10 or pE-C11, no produc-shown to require this motif for cell binding (Chang et al.,
1989; Roivainen et al., 1994). In addition, virus strains tive infection could be achieved, the RGD-mediated cell
recognition appears to be the only means for attachmentexpressing capsid proteins of strain Hill, i.e., E9/Hill,
rE9H-474ic, and rE9-C4, are not affected. Thus, the RGD- of E9/Barty to GMK cells. To exclude the possibility that
these cells are simply not susceptible for a possiblemediated virus–cell interaction appears to be specific
and relevant for E9/Barty. second pathway, additional cell lines will be tested in
further experiments, since it has been shown for cox-This conclusion is also supported by the finding that
destruction of the RGD motif by site-directed mutagene- sackievirus A9 that virus strains with a mutated RGD
motif are infectious in certain cell lines (Hughes et al.,sis results in loss of infectivity of the in vitro transcribed
1995).
The region forming a putative receptor-binding site of
E9/Hill has not yet been identified. However, since rE9-
FIG. 6. Schematic diagram of the polyproteins of plasmids pE9-C1
and pE9-C4. E9/Barty derived sequence is represented by the filledFIG. 5. Changes in virus titer in the muscle tissue of newborn mice
infected with recombinant echo 9 viruses. Four newborn mice were bar, and E9/Hill derived sequence by the open bar. For the 310-aa
fragment, amino acid deviations between E9/Barty (above the line) andinjected subcutaneously each with 1.6 1 105 PFU/20 ml of strain rE9-
C1, 9.6 1 106 PFU/20 ml of strain rE9-C2, and 1.7 1 107 PFU/20 ml of E9/Hill (below the line) sequences are displayed in the one-letter code.
On top, the 10-aa ‘‘RGD insertion’’ of strain Barty is depicted in compari-strain rE9-C4, respectively. After 3 and 5 days p.i. two mice in each
group were harvested, and the virus titers were individually determined son to the Hill sequence. (/) pathogenic phenotype; (0) apathogenic
phenotype.by plaque assay.
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TABLE 2
Blocking Effect of RGD-Containing Peptides against Echovirus 9 Infection
Inhibition (%)
Peptide Hill rE9H rE9-C4 Barty rE9B rE9-C1 rE9-C2 CoxA9a
RGD 10 10 10 53 50 49 52 45
(GRGDS)4 10 10 10 71 71 72 68 73
LTFPRGDNVATA 10 — b — 53 — — — 48
LTFPRGENVATA 10 — — 10 — — — 10
Note. Confluent GMK cell monolayers were preincubated with different peptides (7.5 mM) and infected with standard amounts of the indicated
viruses. The protective effect was determined by calculating the number of plaques after 2 days of incubation in comparison with untreated controls.
a The coxsackievirus A9 served as positive control for a virus with functional RGD motif.
b Not tested.
C1 is inhibited by RGD peptides and since apparently no constructs, pE9-C8 combines the E9/Hill-derived 3*-part
with the RGD motif and the protein 2A of E9/Barty, possi-other—i.e., ‘‘Hill-specific’’—alternative receptor is being
used, it is likely that the site mediating cell attachment bly leading to the noninfectious character.
Our study reveals that a 310-aa fragment containing anof E9/Hill is also located at the C-terminal part of VP1,
3* of nt 2981. RGD motif is essential for attachment of mouse-virulent
echovirus 9 strains and possibly a major determinant ofWe can only speculate about the noninfectious charac-
ter of pE9-C8. It is conceivable that the internal 310-aa virulence of two serologically closely related echovirus
9 strains.Barty fragment (nt 2982– 3911) does not allow productive
infection within the genetic background of rE9/Hill, e.g.,
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